Background: Sexual dysfunction (SD) among male psychiatric patients is common and may be the result of various bio- psycho-social factors. This study aimed to assess the proportion of men with depression and/or anxiety disorders having SD and evaluate its association with sociodemographic and clinical variables. Methods: This cross-sectional study conducted from November 2018 to June 2020 included 100 men attending the psychiatry outpatient department of a tertiary care hospital. Sociodemographic and clinical variables, including diagnosis based on International Classification of Diseases 10th Revision criteria, were assessed. Sexual functioning was measured by the Change in Sexual Functioning Questionnaire-Male Version (CSFQ-M). Results: In the study, sexual pleasure dysfunction, sexual desire dysfunction, sexual desire/interest dysfunction, sexual arousal/erection dysfunction, and sexual orgasmic dysfunction were 71%, 71%, 66%, 68%, and 73%, respectively. Pearson correlation between Hamilton Depression Rating Scale score and sexual desire/interest component of CSFQ-M was r = 0.209 ( P = .008). Correlation between Hamilton Anxiety Rating Scale score and sexual desire/frequency component was r = 0.095 ( P = .012), sexual desire/interest component yielded r = 0.114 ( P = .029) and sexual arousal/erection component yielded r = 0.134 ( P = .052). Conclusions: Certain areas of sexual functioning are impacted by depression and/or anxiety disorders symptoms. The hypothesis that those with depression and/or anxiety would have lesser overall sexual functioning is supported in some areas by the results. Clinicians should be vigilant of this association and should plan treatment to enhance compliance and outcome.

measured by lost workdays in the past 12 months. An ordered logistic regression was used to determine the impact of financial access on patients' out-of-pocket costs (less than $2,000, $2,000 -4,999, $5,000 or more). In addition, a negative binomial regression was implemented to estimate the impact on productivity loss caused by financial access barriers. Results: A total of 8,818 and 22,338 cancer survivors were identified out of 717,513 respondents for assessing the impact on productivity loss and out-of-pocket-costs, respectively. The financial access barrier was associated with increased productivity loss compared to those without barriers, [IRR= 1.16, (95% CI: 1.00 to 1.35, P=0.045)]. Not surprisingly, increased financial barriers were associated with higher patients' out-of-pocket costs, [OR= 1.56, (95% CI: 1.73 to 1.80, P =0.007)]. Conclusions: Cancer survivors with financial access barriers are more likely to lose productivity and pay a higher level of out-of-pocket costs, suggesting inequality in health care access can further exacerbate the societal burden of cancer in addition to direct medical costs.

Background: Depressive syndrome is a complex mental illness with multiple symptomatic dimensions comprising affective, cognitive and physical symptoms. Anxiety is behavioral, affective, physical and cognitive responses to perception of danger. There is increased evidence of increasing prevalence of these mental illnesses. Insomnia is an important feature in patients of depression and anxiety disorders. To st Aim: udy the occurrence and functional consequences of insomnia in adult patients of depression and/ or anxiety disorders Total 60 pati Material And Methods: ents aged 18-60 years were recruited as per inclusion and exclusion criteria. The socio demographic details were gathered using semi- structured socio demographic proforma. Insomnia severity index was administered to evaluate the occurrence and severity of insomnia and WHO DAS2.0 scale was applied to measure the functional consequences of insomnia. The Result: main ndings of our study showed that all the demographic characteristics were comparable among the three diagnostic groups and the differences observed were statistically insignicant.The association between diagnostic groups and Functionalconsequences where mobility and life activities were signicantly higher inthe subjects with co morbid depression and anxiety disorders, whereas other consequences were associated insignicantly. It was observed that all the functional consequences increase signicantly as the ISI grading increases from absent to severe. Sleepiness, sl Conclusion: eep quality, and insomnia severity were consistently poorer in subjects with both depression and anxiety. Anxiety and depression affect insomnia in a supra-additive manner.